V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009053 | 190002566 | null | null | null | 2018-12-22 | 2018-12-26 | Cisplatin + Vinorelbine (PO) | 02 | null | MAP | 101839812 |
| 190009058 | 190002568 | null | null | null | null | 2019-06-12 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100979612 |
| 190009061 | 190002570 | null | null | null | null | 2018-08-23 | null | null | null | DOXORUBICIN + METHOTREXATE | 100885096 |
| 190009063 | 190002571 | null | null | null | null | 2016-10-15 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 101806747 |
| 190009074 | 190002574 | 1.78 | 74.4 | Neo-adjuvant (N) | 2017-10-07 | 2017-10-10 | MAP | 01 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100895919 |
| 190009075 | 190002575 | 1.58 | 69.1 | Palliative (P) | 2016-11-11 | 2016-12-06 | PAM x 2 pre-surgery (cycles 1&2) | null | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100596210 |
| 190009084 | 190002578 | null | null | null | null | 2018-02-09 | Doxorubicin 75mg/m2 | null | null | EW EUROEWING 2012 ARM A VAC | 100122474 |
| 190009091 | 190002580 | 0 | 94 | Palliative (P) | 2017-04-12 | 2017-04-12 | Cisplatin + Doxorubicin | null | N | CISPLATIN + DOXORUBICIN | 100295061 |
| 190009105 | 190002584 | 1.83 | 105.8 | Palliative (P) | 2019-03-25 | 2019-03-26 | Abiraterone | 02 | N | DOXORUBICIN + METHOTREXATE | 101095251 |
| 190009107 | 190002585 | 1.71 | 52.2 | Curative (C) | 2020-02-22 | 2020-03-10 | CHOP R | 02 | N | DOXORUBICIN + METHOTREXATE | 101130934 |
| 190009108 | 190002586 | null | null | null | null | 2019-10-24 | R Chlorambucil | null | null | VIDE | 101069425 |
| 190009114 | 190002587 | 0 | 65 | null | 2019-03-12 | 2019-03-12 | Carboplatin AUC 6 - 10 | null | null | TRIAL | 100708674 |
| 190009117 | 190002588 | null | null | null | null | 2017-05-10 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101452979 |
| 190009119 | 190002589 | null | null | null | null | 2020-01-14 | DOCETAXEL + GEMCITABINE | null | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100889289 |
| 190009121 | 190002590 | null | null | null | null | 2018-08-19 | Capecitabine + Cisplatin | null | null | NOT MATCHED | 101508406 |
| 190009122 | 190002591 | null | null | null | null | 2018-09-10 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100531019 |
| 190009132 | 190002592 | null | null | null | null | 2017-05-29 | Cisplatin + Radiotherapy | null | null | CARBOPLATIN + ETOPOSIDE | 101351144 |
| 190009134 | 190002593 | 1.72 | 76 | Curative (C) | 2014-12-06 | 2014-12-06 | ECX | 02 | N | EURAMOS TRIAL | 100979678 |
| 190009136 | 190002594 | null | null | null | null | 2018-05-02 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100257224 |
| 190009142 | 190002596 | null | null | null | null | 2018-03-03 | DOXORUBICIN | null | null | STS NON-RHABDO EPSSG 2005 IE | 101237553 |
| 190009143 | 190002597 | null | null | null | null | 2019-08-17 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100838550 |
| 190009146 | 190002598 | 1.68 | 90.3 | null | 2019-07-20 | 2019-07-23 | Irinotecan + Modified De Gramont | 2 | null | DOXORUBICIN + HD MTX | 101041615 |
| 190009147 | 190002599 | null | null | null | null | 2016-08-04 | FLUOROURACIL + OXALIPLATIN | null | null | EW EUROEWING 2012 ARM B IE | 100431399 |
| 190009149 | 190002600 | null | null | null | null | 2017-05-11 | PAM x 2 pre-surgery (cycles 1&2) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101726065 |
| 190009152 | 190002601 | null | null | null | null | 2019-04-08 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | DOXORUBICIN + METHOTREXATE | 100349515 |
| 190009154 | 190002602 | 1.78 | 67.2 | Curative (C) | 2018-06-03 | 2018-06-05 | Cisplatin + Doxorubicin | 01 | N | CISPLATIN + DOXORUBICIN | 100324943 |
| 190009155 | 190002603 | null | null | null | null | 2017-03-23 | EW EuroEwing 2012 Arm B VDC | null | null | LANREOTIDE | 100425885 |
| 190009163 | 190002607 | 1.86 | 90 | 03 | 2016-08-20 | 2016-08-21 | EURAMOS TRIAL | 02 | N | EW EUROEWING 99 : VIDE | 101340636 |
| 190009181 | 190002610 | null | null | null | null | 2020-01-07 | null | null | null | METHOTREXATE HIGH DOSE | 100711497 |
| 190009188 | 190002614 | null | null | null | null | 2021-01-08 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101419787 |
| 190009190 | 190002616 | null | null | null | null | 2018-09-13 | CARBOPLATIN + PACLITAXEL | null | null | EW EUROEWING 2012 ARM A VIDE | 101769791 |
| 190009193 | 190002618 | 1.5 | 78.7 | Palliative (P) | 2018-09-16 | 2018-09-25 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101185191 |
| 190009199 | 190002620 | null | null | null | null | 2019-12-31 | Dox + HD Mtx (post PAM) | null | null | CAV | 100495310 |
| 190009201 | 190002622 | 1.85 | 64 | Neo-adjuvant (N) | 2020-10-09 | 2020-10-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | DOXORUBICIN + HD MTX | 101399655 |
| 190009204 | 190002623 | null | null | null | null | 2017-07-22 | CISPLATIN + FLUOROURACIL | null | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101767591 |
| 190009209 | 190002625 | 0 | 75.6 | Palliative (P) | 2015-05-29 | 2015-05-29 | ECX | 02 | N | MAP | 100824684 |
| 190009210 | 190002626 | null | null | null | null | 2019-09-14 | VIDE | null | null | DOXORUBICIN + METHOTREXATE | 100052124 |
| 190009212 | 190002627 | 1.66 | 47.2 | Palliative (P) | 2017-04-27 | 2017-04-27 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 101402106 |
| 190009214 | 190002628 | null | null | null | null | 2016-07-21 | CISPLATIN + FLUOROURACIL | null | null | MAP | 101166766 |
| 190009215 | 190002629 | null | null | null | null | 2018-11-15 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 100645235 |
| 190009217 | 190002630 | 1.75 | 88.5 | null | 2017-12-21 | 2017-12-22 | Gemcitabine + Capecitabine | null | null | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100246119 |
| 190009220 | 190002631 | 0 | 26 | Neo-adjuvant (N) | 2018-11-18 | 2018-12-13 | Gemcitabine + Capecitabine | N | N | EURO-EWING | 100574011 |
| 190009225 | 190002633 | null | null | null | null | 2018-07-25 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101047087 |
| 190009226 | 190002634 | 1.83 | 46.2 | null | 2016-04-23 | 2016-04-23 | Cyclophosphamide + Docetaxel | 02 | null | EURAMOS TRIAL | 101766662 |
| 190009232 | 190002636 | null | null | null | null | 2018-06-16 | EURAMOS TRIAL | null | null | DOXORUBICIN + METHOTREXATE | 100547903 |
| 190009234 | 190002637 | null | null | null | null | 2018-09-12 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 100294296 |
| 190009237 | 190002638 | null | null | null | null | 2016-12-30 | ECX | null | null | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 101461415 |
| 190009238 | 190002639 | null | null | null | null | 2014-12-15 | Cisplatin + Radiotherapy + CISPLATIN | null | null | TRIAL UNSPECIFIED | 100985394 |
| 190009240 | 190002640 | 1.79 | 83.2 | Palliative (P) | 2018-11-30 | 2018-12-04 | Gemcitabine + Capecitabine | 02 | N | EURAMOS TRIAL | 100795731 |
| 190009242 | 190002641 | 1.5 | 47 | Adjuvant (A) | 2018-08-18 | 2018-08-19 | CARBOPLATIN + RT | 02 | N | EW EUROEWING 99 : VIDE | 100579455 |